Inventor
HAYS PUTNAM ANNA-MARIA A
US25 patents
⚠️ This page may combine multiple inventors who share the name “HAYS PUTNAM ANNA-MARIA A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMBRX INC
14 patentsUS8012931B2Sep 6, 2011
Modified FGF-21 polypeptides and their uses
AMBRX INC76 citations98
US8383365B2Feb 26, 2013
Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives
AMBRX INC48 citations96
US8053560B2Nov 8, 2011
Modified human plasma polypeptide or Fc scaffolds and their uses
AMBRX INC40 citations96
US7919591B2Apr 5, 2011
Modified human plasma polypeptide or Fc scaffolds and their uses
AMBRX INC41 citations96
US9975936B2May 22, 2018
Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids
AMBRX INC12 citations92
US9079971B2Jul 14, 2015
Modified FGF-21 polypeptides comprising non-naturally occurring amino acids
AMBRX INC19 citations92
US8022186B2Sep 20, 2011
Modified human plasma polypeptide or Fc scaffolds and their uses
AMBRX INC20 citations92
US9517273B2Dec 13, 2016
Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids
AMBRX INC15 citations91
US10961291B2Mar 30, 2021
Modified FGF-21 polypeptides and their uses
AMBRX INC1 citations72
US10377805B2Aug 13, 2019
Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses
AMBRX INC2 citations72
US9644014B2May 9, 2017
Modified animal erythropoietin polypeptides and their uses
AMBRX INC3 citations71
US11993637B2May 28, 2024
Modified FGF-21 polypeptides with non-naturally encoded amino acids
AMBRX INC0 citations62
US11542310B2Jan 3, 2023
Modified bovine G-CSF polypeptides and their uses
AMBRX INC0 citations61
US9156899B2Oct 13, 2015
Modified animal erythropoietin polypeptides and their uses
AMBRX INC2 citations60